These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12591534)

  • 41. A short-course therapy with FTY720 prolongs allograft survival after canine kidney transplantation.
    Omura T; Suzuki T; Shimamura T; Jin MB; Yokota R; Fukai M; Iida J; Taniguchi M; Magata S; Horiuchi H; Yamashita K; Nomura M; Kishida A; Matsushita M; Furukawa H; Todo S
    Transplant Proc; 1999 Nov; 31(7):2783-4. PubMed ID: 10578289
    [No Abstract]   [Full Text] [Related]  

  • 42. Novel insights into the mechanism of action of FTY720 in a transgenic model of allograft rejection: implications for therapy of chronic rejection.
    Habicht A; Clarkson MR; Yang J; Henderson J; Brinkmann V; Fernandes S; Jurewicz M; Yuan X; Sayegh MH
    J Immunol; 2006 Jan; 176(1):36-42. PubMed ID: 16365393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FTY720: mechanisms of action and its effect on organ transplantation (review).
    Suzuki S
    Transplant Proc; 1999 Nov; 31(7):2779-82. PubMed ID: 10578288
    [No Abstract]   [Full Text] [Related]  

  • 44. The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection.
    Commodaro AG; Pedregosa JF; Peron JP; Brandão W; Rizzo LV; Bueno V
    Clinics (Sao Paulo); 2012 Jul; 67(7):805-13. PubMed ID: 22892927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing.
    Chiba K; Yanagawa Y; Kataoka H; Kawaguchi T; Ohtsuki M; Hoshino Y
    Transplant Proc; 1999; 31(1-2):1230-3. PubMed ID: 10083549
    [No Abstract]   [Full Text] [Related]  

  • 46. Prolonged graft survival induced by CTLA4IG-gene transfection combined with FTY720 administration in rat heart grafting.
    Kita Y; Li XK; Funeshima N; Enosawa S; Tamura A; Hayashi S; Suzuki K; Kazui T; Amemiya H; Suzuki S
    Transplant Proc; 1999 Nov; 31(7):2787-8. PubMed ID: 10578291
    [No Abstract]   [Full Text] [Related]  

  • 47. Combined therapy of CTLA4Ig-gene transfection with FTY720 administration in rat lung allografts.
    Kita Y; Nogimura H; Ida M; Kageyama Y; Ohi S; Ito Y; Matsushita K; Takahashi T; Suzuki K; Kazui T; Hayashi S; Li X; Suzuki S
    Transplant Proc; 2002 Aug; 34(5):1437-40. PubMed ID: 12176429
    [No Abstract]   [Full Text] [Related]  

  • 48. Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival.
    Yin N; Zhang N; Xu J; Shi Q; Ding Y; Bromberg JS
    Transplantation; 2011 Jul; 92(1):25-30. PubMed ID: 21508896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adoptive transfer of FTY720-treated immature BMDCs significantly prolonged cardiac allograft survival.
    Heng Y; Ma Y; Yin H; Duan L; Xiong P; Xu Y; Feng W; Fang M; Tan Z; Chen Y; Zheng F; Gong F
    Transpl Int; 2010 Dec; 23(12):1259-70. PubMed ID: 20536794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The thymus is required for the ability of FTY720 to prolong skin allograft survival across different histocompatibility MHC barriers.
    del Rio ML; Pabst O; Ramirez P; Penuelas-Rivas G; Förster R; Rodriguez-Barbosa JI
    Transpl Int; 2007 Oct; 20(10):895-903. PubMed ID: 17854447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protection of mouse small bowel allografts by FTY720 and costimulation blockade.
    Yan S; Rodriguez-Barbosa JI; Pabst O; Beckmann JH; Brinkmann V; Förster R; Hoffmann MW
    Transplantation; 2005 Jun; 79(12):1703-10. PubMed ID: 15973172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FTY720 inhibits TH1-mediated allogeneic humoral immune response.
    Peñuelas-Rivas G; Domínguez-Perles R; Brinkmann V; Del Rio ML; Muñoz-Luna A; Ramírez-Romero P; Parrilla-Paricio P; Rodríguez-Barbosa JI
    Transplant Proc; 2005 Nov; 37(9):4124-6. PubMed ID: 16386642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate.
    Chiba K; Hoshino Y; Ohtsuki M; Kataoka H; Maeda Y; Matsuyuki H; Sugahara K; Kiuchi M; Hirose R; Adachi K
    Transplant Proc; 2005; 37(1):102-6. PubMed ID: 15808561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of T cell homeostasis and alloreactivity under continuous FTY720 exposure.
    Metzler B; Gfeller P; Wieczorek G; Li J; Nuesslein-Hildesheim B; Katopodis A; Mueller M; Brinkmann V
    Int Immunol; 2008 May; 20(5):633-44. PubMed ID: 18343890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation.
    Hwang MW; Matsumori A; Furukawa Y; Ono K; Okada M; Iwasaki A; Hara M; Sasayama S
    Circulation; 1999 Sep; 100(12):1322-9. PubMed ID: 10491378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunosuppressive effect of S1P1 receptor agonist FTY720].
    Zhou WQ; Zhang HJ; Jin J; Li Y; Li C; Chen XG
    Yao Xue Xue Bao; 2012 Apr; 47(4):546-50. PubMed ID: 22799042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination effect of tacrolimus and FTY720 in liver transplantation in rats.
    Tamura A; Li XK; Funeshima N; Enosawa S; Amemiya H; Suzuki S
    Transplant Proc; 1999 Nov; 31(7):2785-6. PubMed ID: 10578290
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of a new immunosuppressant, FTY720, on joint allografts.
    Watanabe H; Hamada Y; Toshima T; Nagasawa K; Sakano Y
    J Reconstr Microsurg; 1999 May; 15(4):295-8. PubMed ID: 10363553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: II. Effect of FTY720 and FTY720-phosphate on host-versus-graft and graft-versus-host reaction in mice.
    Kataoka H; Ohtsuki M; Shimano K; Mochizuki S; Oshita K; Murata M; Sugahara K; Sato N; Hoshino Y; Chiba K
    Transplant Proc; 2005; 37(1):107-9. PubMed ID: 15808562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.